Physician profile
Katrina Bailey
NPI 1518177096
$824.57
in general payments reported to CMS, 2019-2025
16 companies · $28.23 in 2025
The $28.23 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $323 · 2022: $63.65 · 2023: $374 · 2024: $36.04 · 2025: $28.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411 · Education: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.30 |
| Education | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $200.51 | 2023 | Altis |
| Medtronic, INC. | $103.37 | 2023 | Interstim |
| Teleflex LLC | $88.81 | 2021 | |
| Axonics, INC. | $65.44 | 2021-2023 | Bulkamid |
| Astellas Pharma US INC | $60.00 | 2021 | |
| Janssen Biotech, INC. | $48.33 | 2021 | |
| Myovant Sciences INC. | $40.65 | 2021-2022 | |
| Boston Scientific Corporation | $36.04 | 2024 | Ams 700 |
| Abbvie INC. | $30.15 | 2022-2023 | |
| Rochester Medical Corporation | $28.80 | 2022 | |
| Myriad Genetic Laboratories, INC. | $28.23 | 2025 | Prolaris |
| 180 Medical, INC. | $28.18 | 2023 | Gentlecath Glide |
| Pfizer INC. | $19.15 | 2021 | |
| Sumitomo Pharma America, INC. | $16.47 | 2023 | Gemtesa |
| Convatec INC. | $15.92 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih INC. | $14.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.